Biomea Fusion
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
BMEA Key Statistics
Stock Snapshot
Biomea Fusion(BMEA) stock is priced at $1.31, giving the company a market capitalization of 93.99M. It carries a P/E multiple of -1.47.
On 2026-07-21, Biomea Fusion(BMEA) stock traded between a low of $1.31 and a high of $1.31. Shares are currently priced at $1.31, which is 0.0% above the low and 0.0% below the high.
Biomea Fusion(BMEA) shares are trading with a volume of 1.02K, against a daily average of 830.32K.
In the last year, Biomea Fusion(BMEA) shares hit a 52-week high of $2.99 and a 52-week low of $0.87.
In the last year, Biomea Fusion(BMEA) shares hit a 52-week high of $2.99 and a 52-week low of $0.87.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.